Burden analyses derived from FANCM sequencing, but also genotyping of the single most common variants, have shown that FANCM PTVs are generally associated with ER-negative or triple-negative breast cancer (TNBC, reviewed in [13]). This evidence concerns the gene FANCM and triple-negative breast carcinoma.